An Interview With Dr. Andrew Wilson, Scientific Director of the Alpha-1 Foundation

from Rare Care Podcast · host Rare Disease Advisor

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Andrew Wilson, MD, scientific director of the Alpha-1 Foundation, about the latest therapies to treat alpha-1 antitrypsin deficiency, an incurable genetic disease that causes both lung and liver damage.

Episode metadata supplied by the publisher feed · Published May 31, 2026

Embed this episode

Attribution link and audio player

Ready to play

An Interview With Dr. Andrew Wilson, Scientific Director of the Alpha-1 Foundation

0:00 7:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Rare Care Podcast?

This episode is 7 minutes long.

When was this Rare Care Podcast episode published?

This episode was published on May 31, 2026.

Can I download this Rare Care Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!